Cancer drugs are closing in on some of the deadliest mutations
- PMID: 36284185
- DOI: 10.1038/d41586-022-03392-2
Cancer drugs are closing in on some of the deadliest mutations
Keywords: Biotechnology; Cancer; Drug discovery.
Comment on
-
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor.J Med Chem. 2022 Feb 24;65(4):3123-3133. doi: 10.1021/acs.jmedchem.1c01688. Epub 2021 Dec 10. J Med Chem. 2022. PMID: 34889605
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
